GROW

London, United Kingdom Founded: 2017 • Age: 9 yrs
A biopharmaceutical company focused on cannabis-based medicines for patients.

About GROW

GROW is a company based in London (United Kingdom) founded in 2017 by Ian Atkinson and Ben Langley. It operates as a Direct-to-Consumer (D2C) and B2B2C. GROW has raised $12.62 million across 2 funding rounds. The company has 13 employees. GROW has completed 1 acquisition, including Sanoid. GROW offers products and services including Cannabis-Based Medicinal Products, Medical Cannabis Flowers, and Medical Cannabis Oils. GROW operates in a competitive market with competitors including ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.

  • Headquarter London, United Kingdom
  • Employees 13
  • Founders Ian Atkinson, Ben Langley
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website growgroupplc.com
  • Social LinkedIn X
  • Legal Name Grow Group Ltd
Key Metrics
  • Annual Revenue
    $7.07 M (USD)
    469
    as on Dec 31, 2021
  • Net Profit
    -$1.99 M (USD)
    32
    as on Dec 31, 2021
  • EBITDA
    -$2.1 M (USD)
    31
    as on Dec 31, 2021
  • Total Equity Funding
    $12.62M (USD)

    in 2 rounds

  • Latest Funding Round
    $4.68M (USD), Series C

    Aug 2021

  • Employee Count
    13
  • Investments & Acquisitions

Products & Services of GROW

GROW offers a comprehensive portfolio of products and services, including Cannabis-Based Medicinal Products, Medical Cannabis Flowers, and Medical Cannabis Oils.

Cannabis-Based Medicinal Products
Pharmaceuticals

Medicinal cannabis products are provided for various conditions.

Medical Cannabis Flowers
Pharmaceuticals

Herbal cannabis flowers are offered for vaporization use.

Medical Cannabis Oils
Pharmaceuticals

Cannabis oils are supplied for sublingual administration.

Funding Insights of GROW

GROW has successfully raised a total of $12.62M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $4.68 million completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $12.62M
  • Total Rounds 2
  • Last Round Series C β€” $4.68M
  • First Round $7.95M

    (Nov 2020)

All 2 funding rounds of GROW with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2021$4.68MSeries C––
–
Nov 2020$7.95MSeries C––
–

People of GROW

7 people are tracked at GROW (5 in leadership, 2 in team); the tracked headcount is 13.

NameRoleGroup
Ian Atkinson
Co-Founder & Chief Science OfficerLeadership
Ben Langley
Co-Founder & Chief Executive OfficerLeadership
Mark Lee
Interim CFOLeadership
Nigel Page
Non Executive DirectorLeadership
Dean Gainsley
Non Executive DirectorLeadership
Hannah Nommé
Investor Relations & Community LeadTeam
Joséphine McFarlane
Digital Marketing LeadTeam
Premium access

Complete people profiles for GROW

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by GROW

GROW has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sanoid.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Cannabinoid cosmetics, nutraceuticals, and pharmaceuticals are cultivated and manufactured.
sanoid.comCordoba, Spain2018Aug 2021β€’β€’β€’β€’
Premium access

Complete acquisition details for GROW

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of GROW

4 dated milestones of GROW across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded GROW is founded.
  2. Funding First funding round of $7.9M.
  3. Acquisition Acquires Sanoid.
  4. Funding Latest funding round, Series C, of $4.7M.

Competitors of GROW

GROW operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
zyus.com2018Saskatoon, Canada$19.5M–
Cannabis-derived therapeutics for multiple indications are developed.
sanitygroup.com2011Berlin, Germany$108.79M–
Developer of cannabinoid-based pharmaceuticals and well-being products
terraflos.com2021Uruguay$8M–
Medical cannabis products are provided based on GMP processes.
avicanna.com2016Toronto, Canada$5.94M–
Plant-derived cannabinoid products are developed for medical and consumer uses.
littlegreenpharma.com2016Perth, Australia$1.91M–
Manufacturer of medicinal cannabis for therapeutic use
imcannabis.com2008Herzliya, Israel––
Developer of medical cannabis products
neocannbio.com2021Seoul, South Korea$10.9M–
Cannabinoid-based pharmaceuticals and production technologies are developed.
aleafiahealth.com2007Vaughan, Canada––
Cultivator and producer of cannabis plant for consumer wellness and research applications
Premium access

Detailed competitors of GROW

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of GROW

The website of GROW (growgroupplc.com) receives about 1.9K visits a month.

  • Monthly visits
    1.9K

    ▲ 22.3% vs previous month

Latest news on Grow

Premium access

Complete news archive for GROW

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to GROW

10 companies that operate in the same segment as GROW (Cannabis Health Tech Ecosystem), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Cannabis products are provided to support consumer wellness and health.
2013Smiths Falls, Ontario, Canada–USD 204.24 M960
Online marketplace platform for cannabis traders
2015New York, New York, United StatesUSD 195.4 M––
Loyalty and marketing solutions for cannabis dispensaries are provided.
2012West Palm Beach, Florida, United StatesUSD 25.79 MUSD 22.83 M–
An online marketplace for cannabis products is operated.
2017Bend, Oregon, United StatesUSD 603 M–137
Online platform for cannabis strains, reviews, and ratings
2010Seattle, Washington, United StatesUSD 40.7 M––
Provider of cannabis products, brands, and international business development investments
2013Moncton, New Brunswick, Canada–USD 186.16 M898
ERP software is offered via cloud platform for cannabis operations.
2018Boston, Massachusetts, United States–USD 110.08 M313
Online marketplace connecting licensed cannabis vendors and dispensaries
2015Chicago, Illinois, United StatesUSD 22.57 M––
Enterprise software is provided for cannabis dispensary management.
2016Oakland, California, United StatesUSD 75.5 MUSD 148.97 K97
Proprietary medical cannabis strains are developed and offered.
2014Maryland Heights, Missouri, United StatesUSD 156 M–557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about GROW

GROW was founded in 2017 and raised its 1st funding round 3 years after it was founded.

GROW is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Ben Langley is the current CEO of GROW. They have also founded this company.

GROW is a funded company, having raised a total of $12.62M across 2 funding rounds to date. The company's 1st funding round was a Series C of $7.95M, raised on Nov 2020.

GROW has 13 employees.

Annual revenue of GROW is $7.07M as on Dec 31, 2021.

GROW Group LTD is a biopharmaceutical entity established in 2017, dedicated to the development and supply of cannabis-based medicinal products. Operations are conducted through a vertically integrated model and partnerships to ensure a broad supply of differentiated medicines. The company targets various medical conditions such as epilepsy, cancer, and chronic pain across multiple regions including the UK, Germany, and Iberia. Solutions are provided to improve patient outcomes through innovative approaches and consistent supply chains.

GROW's top competitors include Avicanna, ZYUS Life Sciences and Neocannbio.

GROW offers Cannabis-Based Medicinal Products, Medical Cannabis Flowers, and Medical Cannabis Oils.

GROW has made 1 acquisition, including Sanoid.

GROW operates through Grow Group Ltd.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available